Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor
Détails
ID Serval
serval:BIB_9A7A372B8DFA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor
Périodique
Am J Hematol
ISSN
0361-8609 (Print)
ISSN-L
0361-8609
Statut éditorial
Publié
Date de publication
05/2007
Volume
82
Numéro
5
Pages
417-8
Langue
anglais
Notes
Schleinitz, N
Ebbo, M
Mazodier, K
Poullin, P
Bernit, E
Veit, V
Veyradier, A
Fakhouri, F
Kaplanski, G
Harle, J-R
eng
Case Reports
Letter
Am J Hematol. 2007 May;82(5):417-8. doi: 10.1002/ajh.20764.
Ebbo, M
Mazodier, K
Poullin, P
Bernit, E
Veit, V
Veyradier, A
Fakhouri, F
Kaplanski, G
Harle, J-R
eng
Case Reports
Letter
Am J Hematol. 2007 May;82(5):417-8. doi: 10.1002/ajh.20764.
Mots-clé
ADAM Proteins/*immunology, ADAMTS13 Protein, Adult, Antibodies, Monoclonal/*therapeutic use, Antibodies, Monoclonal, Murine-Derived, Autoantibodies/blood/immunology, Autoimmune Diseases/*drug therapy/immunology/therapy, Female, Humans, Plasma Exchange, Pregnancy, Pregnancy Complications, Hematologic/immunology/therapy, Purpura, Thrombotic Thrombocytopenic/*drug therapy/immunology/therapy, Rituximab, Secondary Prevention
Pubmed
Création de la notice
01/03/2022 11:18
Dernière modification de la notice
02/03/2022 7:36
Données d'usage
